Phase Ib study of elimusertib (ATRi; BAY 1895344) in combination with niraparib (PARPi) in patients with advanced solid tumors Meeting Abstract
| Authors: | Yap, T. A.; Konstantinopoulos, P.; Grisham, R. N.; Gupta, D.; Wilkinson, G.; Cao, A.; Jeffers, M.; Sharma, N. |
| Abstract Title: | Phase Ib study of elimusertib (ATRi; BAY 1895344) in combination with niraparib (PARPi) in patients with advanced solid tumors |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S767 |
| End Page: | S768 |
| Language: | English |
| ACCESSION: | WOS:000866211600487 |
| DOI: | 10.1016/j.annonc.2022.07.622 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 494TiP -- Source: Wos |
